These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5455632)

  • 1. Disappearance of phenobarbital and diphenylhydantoin from serum of children.
    Garrettson LK; Dayton PG
    Clin Pharmacol Ther; 1970; 11(5):674-9. PubMed ID: 5455632
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 4. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.
    Kupferberg HJ
    Clin Chim Acta; 1970 Aug; 29(2):282-8. PubMed ID: 5493185
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of diphenylhydantoin on primidone metabolism.
    Fincham RW; Schottelius DD; Sahs AL
    Arch Neurol; 1974 Mar; 30(3):259-62. PubMed ID: 4812960
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 8. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW; Schottelius DD
    J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131
    [No Abstract]   [Full Text] [Related]  

  • 10. Decrease in serum diphenylhydantoin levels after withdrawal of phenobarbital in epileptics treated with both drugs.
    Arakawa T; Yoshida T; Tanabu M; Karahashi M; Takagi T
    Tohoku J Exp Med; 1974 Feb; 112(2):165-8. PubMed ID: 4836028
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoglobulins in epilepsy.
    Slavin BN; Fenton GM; Laundy M; Reynolds EH
    J Neurol Sci; 1974 Nov; 23(3):353-7. PubMed ID: 4427121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenobarbital intoxication in a patient with primidone and diphenylhydantoin (author's transl)].
    Galdames D; Ortiz M; Saavedra I; Aguilera L
    Rev Med Chil; 1980 Aug; 108(8):716-20. PubMed ID: 7221259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of the blood levels of phenobarbital, primidone and diphenylhydantoin].
    Bartels H; Kruse K; Oldigs HD
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):572-3. PubMed ID: 876242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between the serum levels of phenobarbital and diphenylhydantoin and clinical data in patients with drug resistant epilepsy.
    Bendarzewska-Nawrocka B; Pietruszewska E; Bacia T
    Monogr Neural Sci; 1980; 5():229-34. PubMed ID: 7322157
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical study of serum primidone levels.
    Booker HE; Hosokowa K; Burdette RD; Darcey B
    Epilepsia; 1970 Dec; 11(4):395-402. PubMed ID: 5278206
    [No Abstract]   [Full Text] [Related]  

  • 19. A practical routine gas chromatographic determination of phenobarbital, primidone and diphenylhydantoin.
    Malkus H; Jatlow PI; Castro A
    Clin Chim Acta; 1978 Jan; 82(1-2):113-7. PubMed ID: 618673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent assay of phenobarbital and diphenylhydantoin in plasma by vapor-phase chromatography.
    Van Meter JC; Buckmaster HS; Shelley LL
    Clin Chem; 1970 Feb; 16(2):135-8. PubMed ID: 5417442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.